@Amgen Amjevita cleared for all eligible indications @US_FDA of #humira @abbvie (a market of nearly $15 billion!) https://t.co/pKMxv9WeAx
@Amgen Amjevita cleared for all eligible indications @US_FDA of #humira @abbvie (a market of nearly $15 billion!) https://t.co/pKMxv9WeAx